Literature DB >> 35971018

Reenacting Neuroectodermal Exposure of Hematopoietic Progenitors Enables Scalable Production of Cryopreservable iPSC-Derived Human Microglia.

Mona Mathews1,2, Jannis Wißfeld3, Lea Jessica Flitsch2, Anahita Shahraz3, Vesselina Semkova2, Yannik Breitkreuz1,2, Harald Neumann3, Oliver Brüstle4,5.   

Abstract

Human microglia, as innate immune cells of the central nervous system (CNS), play a central role in the pathogenesis of a large number of neurological and psychiatric disorders. However, experimental access to primary human microglia for biomedical applications such as disease modeling is extremely limited. While induced pluripotent stem cells (iPSCs) could provide an alternative source of microglia, the reenactment of their complex ontogenesis with a yolk sac origin and subsequent priming upon CNS invasion has remained a challenge. Here, we report a developmentally informed in vitro differentiation method for large-scale production and cryopreservation of iPSC-derived microglia (iPSdMiG). Specifically, iPSCs were propagated in conditions yielding both yolk sac hematopoietic derivatives and early neuroepithelial cells. To enable large-scale production, we implemented 3D bioreactor-based dynamic culture conditions and the use of novel mesh macrocarriers. Under these conditions, microglia could be harvested across a time period of at least 6 weeks, with 1 × 106 iPSCs giving rise to up to 45 × 106 iPSdMiG. The transcriptomic profile of iPSdMiG showed high similarity to adult human microglia, and harvested cells were immunopositive for typical microglial markers. In addition, iPSdMiG were able to secrete pro-inflammatory cytokines, engaged in phagocytotic activity, produced reactive oxygen species and lent themselves to co-culture studies in neural 2D and 3D systems. Importantly, iPSdMiG were efficiently cryopreserved, enabling the establishment of donor-specific microglia cell banks for disease modeling, drug discovery and eventually cell therapy. Main points. Scalable generation of iPSC-derived multi-lineage embryoid bodies on macrocarriers, reproducibly releasing microglia exhibiting characteristic markers and function. Cells are transcriptomically similar to primary human microglia and cryopreservable.
© 2022. The Author(s).

Entities:  

Keywords:  Bioreactor; Human microglia; In vitro differentiation; Induced pluripotent stem cells; Macrocarrier

Year:  2022        PMID: 35971018     DOI: 10.1007/s12015-022-10433-w

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   6.692


  59 in total

1.  Microglia take centre stage in neurodegenerative disease.

Authors:  Michael T Heneka
Journal:  Nat Rev Immunol       Date:  2019-02       Impact factor: 53.106

Review 2.  Microglia Biology: One Century of Evolving Concepts.

Authors:  Marco Prinz; Steffen Jung; Josef Priller
Journal:  Cell       Date:  2019-10-03       Impact factor: 41.582

3.  Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner.

Authors:  Dorothy P Schafer; Emily K Lehrman; Amanda G Kautzman; Ryuta Koyama; Alan R Mardinly; Ryo Yamasaki; Richard M Ransohoff; Michael E Greenberg; Ben A Barres; Beth Stevens
Journal:  Neuron       Date:  2012-05-24       Impact factor: 17.173

4.  Microglia contribute to normal myelinogenesis and to oligodendrocyte progenitor maintenance during adulthood.

Authors:  Nora Hagemeyer; Klara-Maria Hanft; Maria-Anna Akriditou; Nicole Unger; Eun S Park; E Richard Stanley; Ori Staszewski; Leda Dimou; Marco Prinz
Journal:  Acta Neuropathol       Date:  2017-07-06       Impact factor: 17.088

5.  Live imaging of neuronal degradation by microglia reveals a role for v0-ATPase a1 in phagosomal fusion in vivo.

Authors:  Francesca Peri; Christiane Nüsslein-Volhard
Journal:  Cell       Date:  2008-05-30       Impact factor: 41.582

6.  The classical complement cascade mediates CNS synapse elimination.

Authors:  Beth Stevens; Nicola J Allen; Luis E Vazquez; Gareth R Howell; Karen S Christopherson; Navid Nouri; Kristina D Micheva; Adrienne K Mehalow; Andrew D Huberman; Benjamin Stafford; Alexander Sher; Alan M Litke; John D Lambris; Stephen J Smith; Simon W M John; Ben A Barres
Journal:  Cell       Date:  2007-12-14       Impact factor: 41.582

7.  Microglial interactions with synapses are modulated by visual experience.

Authors:  Marie-Ève Tremblay; Rebecca L Lowery; Ania K Majewska
Journal:  PLoS Biol       Date:  2010-11-02       Impact factor: 8.029

8.  A novel microglial subset plays a key role in myelinogenesis in developing brain.

Authors:  Agnieszka Wlodarczyk; Inge R Holtman; Martin Krueger; Nir Yogev; Julia Bruttger; Reza Khorooshi; Anouk Benmamar-Badel; Jelkje J de Boer-Bergsma; Nellie A Martin; Khalad Karram; Isabella Kramer; Erik Wgm Boddeke; Ari Waisman; Bart Jl Eggen; Trevor Owens
Journal:  EMBO J       Date:  2017-09-28       Impact factor: 11.598

Review 9.  Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response.

Authors:  Sara Bachiller; Itzia Jiménez-Ferrer; Agnes Paulus; Yiyi Yang; Maria Swanberg; Tomas Deierborg; Antonio Boza-Serrano
Journal:  Front Cell Neurosci       Date:  2018-12-18       Impact factor: 5.505

10.  Negative feedback control of neuronal activity by microglia.

Authors:  Ana Badimon; Hayley J Strasburger; Pinar Ayata; Xinhong Chen; Aditya Nair; Ako Ikegami; Philip Hwang; Andrew T Chan; Steven M Graves; Joseph O Uweru; Carola Ledderose; Munir Gunes Kutlu; Michael A Wheeler; Anat Kahan; Masago Ishikawa; Ying-Chih Wang; Yong-Hwee E Loh; Jean X Jiang; D James Surmeier; Simon C Robson; Wolfgang G Junger; Robert Sebra; Erin S Calipari; Paul J Kenny; Ukpong B Eyo; Marco Colonna; Francisco J Quintana; Hiroaki Wake; Viviana Gradinaru; Anne Schaefer
Journal:  Nature       Date:  2020-09-30       Impact factor: 69.504

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.